since the drug is increasingly used in secondary prophylaxis of sudden death after myocardial infarction , a trial was designed to confirm or to refute the suspicion that sulfinpyrazone may interfere with natriuresis .
C0027051
myocardial
C0038742
sulfinpyrazone